Tonix Pharmaceuticals Holding Corp (TNXP) valuation · rev $13.1M
Tonix Pharmaceuticals Holding Corp (TNXP) rev $13.1M.
| Metric | Value |
|---|---|
| Market cap | $194.5M |
| Revenue | $13.1M |
| P/S | 14.8 |
| P/B | 0.9 |
TNXP valuation FAQ
What is TNXP's market cap?
Tonix Pharmaceuticals Holding Corp (TNXP) market cap is $194.5M on the latest cached fundamentals snapshot.
What is TNXP's latest revenue?
Latest cached Tonix Pharmaceuticals Holding Corp (TNXP) revenue was $13.1M. Statements: https://lician.com/financials/tnxp
What is TNXP's price-to-sales ratio?
Tonix Pharmaceuticals Holding Corp (TNXP) price-to-sales (P/S) is 14.8, cached market cap $194.5M divided by revenue $13.1M.
What is TNXP's price-to-book ratio?
Tonix Pharmaceuticals Holding Corp (TNXP) price-to-book (P/B) is 0.9 on the latest cached fundamentals snapshot.
How many TNXP valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Tonix Pharmaceuticals Holding Corp (TNXP): Market cap, Revenue, P/S, and P/B.
Where is TNXP valuation listed?
Cached valuation multiples for Tonix Pharmaceuticals Holding Corp (TNXP) are listed at https://lician.com/valuation/tnxp.
Not investment advice. Cached rows, not a live tape.